Allarity Therapeutics, Inc.
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
- Agreement complements revenue from standard gene expression and DRP® services